4740 related articles for article (PubMed ID: 9021355)
1. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
3. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
[TBL] [Abstract][Full Text] [Related]
4. Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days.
Baird DT; Thong KJ; Hall C; Cameron ST
Hum Reprod; 1995 Sep; 10(9):2270-6. PubMed ID: 8530650
[TBL] [Abstract][Full Text] [Related]
5. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
6. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
Messinis IE; Lolis D; Zikopoulos K; Tsahalina E; Seferiadis K; Templeton AA
Hum Reprod; 1994 Aug; 9(8):1437-41. PubMed ID: 7989501
[TBL] [Abstract][Full Text] [Related]
8. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
9. Effect of mifepristone on folliculogenesis in women treated with recombinant FSH.
Messinis IE; Krishnan M; Kazem R; Khadilkar S; Templeton AA
Clin Endocrinol (Oxf); 1997 Mar; 46(3):309-14. PubMed ID: 9156040
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
11. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
12. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
13. Role of gonadotrophin releasing hormone baseline concentrations in the control of pituitary gonadotrophin and ovarian steroid secretion in the pseudopregnant rat.
Schuiling GA; Valkhof N; Koiter TR
Hum Reprod; 1996 Jan; 11(1):13-8. PubMed ID: 8671150
[TBL] [Abstract][Full Text] [Related]
14. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
15. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
Jeppsson S; Rannevik G; Thorell JI; Wide L
Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
[TBL] [Abstract][Full Text] [Related]
16. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
Attardi B; Scott R; Pfaff D; Fink G
J Neuroendocrinol; 2007 Dec; 19(12):988-1000. PubMed ID: 18001329
[TBL] [Abstract][Full Text] [Related]
17. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
18. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
Jeppsson S; Rannevik G; Thorell JI
Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
[TBL] [Abstract][Full Text] [Related]
19. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
20. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.
Messinis IE; Lolis D; Zikopoulos K; Milingos S; Kollios G; Seferiadis K; Templeton AA
Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
